Citations (31)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Ying Meng, Tong Zhao, Zhengyi Zhang & Dekui Zhang. (2022) The role of hepatic microenvironment in hepatic fibrosis development. Annals of Medicine 54:1, pages 2829-2843.
Read now
Read now
Meixin Gao, Xiulan Li, Lingling He, Junru Yang, Xiaohui Ye, Fan Xiao & Hongshan Wei. (2019) Diammonium Glycyrrhizinate Mitigates Liver Injury Via Inhibiting Proliferation Of NKT Cells And Promoting Proliferation Of Tregs. Drug Design, Development and Therapy 13, pages 3579-3589.
Read now
Read now
Salvatore Sutti, Stefania Bruzzì & Emanuele Albano. (2016) The role of immune mechanisms in alcoholic and nonalcoholic steatohepatitis: a 2015 update. Expert Review of Gastroenterology & Hepatology 10:2, pages 243-253.
Read now
Read now
Articles from other publishers (28)
Carlos Cuño-Gómiz, Estefanía de Gregorio, Anna Tutusaus, Patricia Rider, Nuria Andrés-Sánchez, Anna Colell, Albert Morales & Montserrat Marí. (2023) Sex-based differences in natural killer T cell-mediated protection against diet-induced steatohepatitis in Balb/c mice. Biology of Sex Differences 14:1.
Crossref
Crossref
Xu-Rui LiuLian-Shuo LiFei LiuZi-Wei LiXiao-Yu LiuWei Zhang & Dong Peng. (2023) Short-Term and Long-Term Outcomes of Liver Cirrhosis in Gastric Neoplasm Patients Undergoing Endoscopic Submucosal Dissection. Journal of Laparoendoscopic & Advanced Surgical Techniques 33:7, pages 640-647.
Crossref
Crossref
Kunj Vyas & Mayur M Patel. (2023) Insights on drug and gene delivery systems in liver fibrosis. Asian Journal of Pharmaceutical Sciences 18:2, pages 100779.
Crossref
Crossref
Nana Zhang, Huimin Yao, Zhixuan Zhang, Zhuoqun Li, Xue Chen, Yan Zhao, Ran Ju, Jiayi He, Heli Pan, Xiaoli Liu & Yi Lv. (2023) Ongoing involvers and promising therapeutic targets of hepatic fibrosis: The hepatic immune microenvironment. Frontiers in Immunology 14.
Crossref
Crossref
Haoxian Gou, Shenglu Liu, Linxin Liu, Ming Luo, Shu Qin, Kai He & Xiaoli Yang. (2022) Obeticholic acid and 5β-cholanic acid 3 exhibit anti-tumor effects on liver cancer through CXCL16/CXCR6 pathway. Frontiers in Immunology 13.
Crossref
Crossref
Xinyu Gu, Qingfei Chu, Xiao Ma, Jing Wang, Chao Chen, Jun Guan, Yanli Ren, Shanshan Wu & Haihong Zhu. (2022) New insights into iNKT cells and their roles in liver diseases. Frontiers in Immunology 13.
Crossref
Crossref
Mengqin Yuan, Xue Hu, Lichao Yao, Pingji Liu, Yingan Jiang & Lanjuan Li. (2022) Comprehensive bioinformatics and machine learning analysis identify VCAN as a novel biomarker of hepatitis B virus-related liver fibrosis. Frontiers in Molecular Biosciences 9.
Crossref
Crossref
Li Chen, Desong Kong, Siwei Xia, Feixia Wang, Zhanghao Li, Feng Zhang & Shizhong Zheng. (2022) Crosstalk Between Autophagy and Innate Immunity: A Pivotal Role in Hepatic Fibrosis. Frontiers in Pharmacology 13.
Crossref
Crossref
Honghai Xu & Hua Wang. (2022) Immune cells in alcohol-related liver disease. Liver Research 6:1, pages 1-9.
Crossref
Crossref
Wenhui Liu, Xiangchang Zeng, Yating Liu, Jinfeng Liu, Chaopeng Li, Lulu Chen, Hongying Chen & Dongsheng Ouyang. (2021) The Immunological Mechanisms and Immune-Based Biomarkers of Drug-Induced Liver Injury. Frontiers in Pharmacology 12.
Crossref
Crossref
Natalia Vacani-Martins, Marcelo Meuser-Batista, Carina de Lima Pereira dos Santos, Alejandro Marcel Hasslocher-Moreno & Andrea Henriques-Pons. (2021) The Liver and the Hepatic Immune Response in Trypanosoma cruzi Infection, a Historical and Updated View. Pathogens 10:9, pages 1074.
Crossref
Crossref
Wei Wang, Xuelian Huang, Xuzhou Fan, Jingmei Yan & Jianfeng Luan. (2020) Progress in evaluating the status of hepatitis C infection based on the functional changes of hepatic stellate cells (Review). Molecular Medicine Reports.
Crossref
Crossref
Anna E. Barry, Rajkumar Baldeosingh, Ryan Lamm, Keyur Patel, Kai Zhang, Dana A. Dominguez, Kayla J. Kirton, Ashesh P. Shah & Hien Dang. (2020) Hepatic Stellate Cells and Hepatocarcinogenesis. Frontiers in Cell and Developmental Biology 8.
Crossref
Crossref
Erica Novo, Claudia Bocca, Beatrice Foglia, Francesca Protopapa, Marina Maggiora, Maurizio Parola & Stefania Cannito. (2020) Liver fibrogenesis: un update on established and emerging basic concepts. Archives of Biochemistry and Biophysics 689, pages 108445.
Crossref
Crossref
Yue Chang & Hai Li. (2020) Hepatic Antifibrotic Pharmacotherapy: Are We Approaching Success?. Journal of Clinical and Translational Hepatology 8:2, pages 222-229.
Crossref
Crossref
Xuanyan Cai, Jiajia Wang, Jincheng Wang, Qian Zhou, Bo Yang, Qiaojun He & Qinjie Weng. (2020) Intercellular crosstalk of hepatic stellate cells in liver fibrosis: New insights into therapy. Pharmacological Research 155, pages 104720.
Crossref
Crossref
Mariana Mihaila, Ecaterina Bontas & Cecilia Patru. 2020. Liver Diseases. Liver Diseases
53
63
.
Seyed Abbas Mirzaei, Farideh Dinmohammadi, Akram Alizadeh & Fatemeh Elahian. (2019) Inflammatory pathway interactions and cancer multidrug resistance regulation. Life Sciences 235, pages 116825.
Crossref
Crossref
Xin Wei, Jingjing Qian, Weifeng Yao, Liling Chen, Huaqin Guan, Yingxiao Chen, Yaosheng Xie, Hong Lu, Zhuo Zhang, Liang Shi & Xiangyang Lin. (2019) Hyperactivated peripheral invariant natural killer T cells correlate with the progression of HBV‐relative liver cirrhosis. Scandinavian Journal of Immunology 90:2.
Crossref
Crossref
Lili Chen, Jinyang Gu, Yihan Qian, Meng Li, Yongbing Qian, Min Xu, Jichang Li, Yankai Wen, Lei Xia, Jiaxin Li, Qiang Xia, Xiaoni Kong & Hailong Wu. (2019) Deletion of C-C Motif Chemokine Ligand 5 Worsens Invariant Natural Killer T-Cell–Mediated Hepatitis via Compensatory Up-regulation of CXCR2–Related Chemokine Activity. Cellular and Molecular Gastroenterology and Hepatology 7:3, pages 623-639.
Crossref
Crossref
José M. García-Heredia & Amancio Carnero. (2018) Dr. Jekyll and Mr. Hyde: MAP17’s up-regulation, a crosspoint in cancer and inflammatory diseases. Molecular Cancer 17:1.
Crossref
Crossref
Braira Wahid, Amjad Ali, Shazia Rafique, Komal Saleem, Muhammad Waqar, Muhammad Wasim & Muhammad Idrees. (2018) Role of altered immune cells in liver diseases: a review. Gastroenterología y Hepatología 41:6, pages 377-388.
Crossref
Crossref
Braira Wahid, Amjad Ali, Shazia Rafique, Komal Saleem, Muhammad Waqar, Muhammad Wasim & Muhammad Idrees. (2018) Role of altered immune cells in liver diseases: a review. Gastroenterología y Hepatología (English Edition) 41:6, pages 377-388.
Crossref
Crossref
Xunyao Wu & Zhigang Tian. (2017) Gut-liver axis: gut microbiota in shaping hepatic innate immunity. Science China Life Sciences 60:11, pages 1191-1196.
Crossref
Crossref
Xiaoying Zhou, Yanzheng Gu, Hongying Xiao, Ning Kang, Yonghua Xie, Guangbo Zhang, Yan Shi, Xiaoyu Hu, Eric Oldfield, Xueguang Zhang & Yonghui Zhang. (2017) Combining Vγ9Vδ2 T Cells with a Lipophilic Bisphosphonate Efficiently Kills Activated Hepatic Stellate Cells. Frontiers in Immunology 8.
Crossref
Crossref
Takuma Tsuchida & Scott L. Friedman. (2017) Mechanisms of hepatic stellate cell activation. Nature Reviews Gastroenterology & Hepatology 14:7, pages 397-411.
Crossref
Crossref
Hanmin Li & Lisheng Zhang. (2016) Liver regeneration microenvironment of hepatocellular carcinoma for prevention and therapy. Oncotarget 8:1, pages 1805-1813.
Crossref
Crossref
Qinbo Yang, Jingang Cui, Peiwei Wang, Xiaoye Du, Wenjian Wang, Teng Zhang & Yu Chen. (2016) Changes in interconnected pathways implicating microRNAs are associated with the activity of apocynin in attenuating myocardial fibrogenesis. European Journal of Pharmacology 784, pages 22-32.
Crossref
Crossref